Skip to main content
Clinical Trials/NCT01106911
NCT01106911
Completed
Not Applicable

Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment: a Prospective Study

University of Pittsburgh1 site in 1 country1,080 target enrollmentMay 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Abnormalities
Sponsor
University of Pittsburgh
Enrollment
1080
Locations
1
Primary Endpoint
Number of Participants Without Cancer Who Were Recalled
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The objective of this study is to demonstrate that digital breast tomosynthesis (DBT) in combination with full field digital mammography (FFDM) has the potential to reduce significantly baseline screening recall rates without a loss in the detection of cancers. The primary hypothesis of the study is that DBT in combination with FFDM will reduce baseline screening mammography recall rates in negative examinations by at least 20%.

Detailed Description

The FFDM images and the FFDM images with the DBT images will be interpreted independently by two experienced radiologists under standard clinical screening procedures. Recommended recall rates will be assessed and compared as a result of each of the two interpretations.

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
September 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jules Sumkin

Chief of Women's Imaging

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • Women between the ages of 34 and
  • Women presenting for their baseline screening mammography examination

Exclusion Criteria

  • Women with a palpable finding(s) via a Breast Self Examination (BSE) or Clinical Breast Examination (CBE).
  • Women who may be or are pregnant by self report
  • Women older than 55 years of age or younger than
  • Women with known fatty breast tissue
  • Males and children
  • Women who are unable to understand or execute written informed consent

Outcomes

Primary Outcomes

Number of Participants Without Cancer Who Were Recalled

Time Frame: upon recruitment/enrollment phase completion

Recall rates of digital breast tomosynthesis and full field digital mammography in younger women undergoing their initial screening mammogram will be assessed and compared.

Study Sites (1)

Loading locations...

Similar Trials